737 related articles for article (PubMed ID: 16342011)
1. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
Schnuch A; Gefeller O; Uter W
Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
[TBL] [Abstract][Full Text] [Related]
2. [Anogenital dermatoses--allergic and irritative causative factors. Analysis of IVDK data and review of the literature].
Kügler K; Brinkmeier T; Frosch PJ; Uter W
J Dtsch Dermatol Ges; 2005 Dec; 3(12):979-86. PubMed ID: 16405714
[TBL] [Abstract][Full Text] [Related]
3. Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group.
Heine G; Schnuch A; Uter W; Worm M
Contact Dermatitis; 2004 Sep; 51(3):111-7. PubMed ID: 15479199
[TBL] [Abstract][Full Text] [Related]
4. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
Proske S; Uter W; Schnuch A; Hartschuh W
Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
[TBL] [Abstract][Full Text] [Related]
5. Contact allergy to neomycin sulfate: results of a multifactorial analysis.
Menezes de Pádua CA; Schnuch A; Lessmann H; Geier J; Pfahlberg A; Uter W
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):725-33. PubMed ID: 15880442
[TBL] [Abstract][Full Text] [Related]
6. Type-IV sensitization profile of individuals with atopic eczema: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG).
Heine G; Schnuch A; Uter W; Worm M; ;
Allergy; 2006 May; 61(5):611-6. PubMed ID: 16629792
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children.
Mailhol C; Lauwers-Cances V; Rancé F; Paul C; Giordano-Labadie F
Allergy; 2009 May; 64(5):801-6. PubMed ID: 19183418
[TBL] [Abstract][Full Text] [Related]
8. Periorbital dermatitis--a recalcitrant disease: causes and differential diagnoses.
Feser A; Plaza T; Vogelgsang L; Mahler V
Br J Dermatol; 2008 Sep; 159(4):858-63. PubMed ID: 18721191
[TBL] [Abstract][Full Text] [Related]
9. Allergic contact dermatitis to topical preparations of bufexamac.
Pan Y; Nixon R
Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
[TBL] [Abstract][Full Text] [Related]
10. Contact allergy to topical drugs: prevalence in a clinical setting and estimation of frequency at the population level.
de Pádua CA; Uter W; Schnuch A
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):377-84. PubMed ID: 16981214
[TBL] [Abstract][Full Text] [Related]
11. [Contact allergies caused by bufexamac].
Geier J; Fuchs T
Med Klin (Munich); 1989 Jul; 84(7):333-8. PubMed ID: 2529420
[TBL] [Abstract][Full Text] [Related]
12. [Contact allergy to bufexamac].
Frosch PJ; Raulin C
Hautarzt; 1987 Jun; 38(6):331-4. PubMed ID: 2958428
[TBL] [Abstract][Full Text] [Related]
13. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
[No Abstract] [Full Text] [Related]
14. Allergic contact dermatitis to topical drugs--epidemiological risk assessment.
de Pádua CA; Schnuch A; Nink K; Pfahlberg A; Uter W
Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):813-21. PubMed ID: 18383004
[TBL] [Abstract][Full Text] [Related]
15. Allergic contact dermatitis in patients with anogenital complaints.
Bauer A; Geier J; Elsner P
J Reprod Med; 2000 Aug; 45(8):649-54. PubMed ID: 10986683
[TBL] [Abstract][Full Text] [Related]
16. [A severe epicutaneous test reaction to the bufexamac in a hemorrhoidal therapeutic preparation].
Bauer A; Greif C; Gebhardt M; Elsner P
Dtsch Med Wochenschr; 1999 Oct; 124(40):1168-70. PubMed ID: 10548947
[TBL] [Abstract][Full Text] [Related]
17. [Severe contact dermatitis caused by Parfenac cream].
Collet E; Lacroix M; Boulitrop Morvan C; Dalac S; Sallin J; Lambert D
Ann Dermatol Venereol; 1993; 120(12):892-3. PubMed ID: 8074349
[TBL] [Abstract][Full Text] [Related]
18. Contact allergy to topical corticosteroids--results from the IVDK and epidemiological risk assessment.
Uter W; de Pádua CM; Pfahlberg A; Nink K; Schnuch A; Lessmann H
J Dtsch Dermatol Ges; 2009 Jan; 7(1):34-41, 34-42. PubMed ID: 18761609
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG).
Löffler H; Becker D; Brasch J; Geier J;
Br J Dermatol; 2005 Apr; 152(4):709-19. PubMed ID: 15840103
[TBL] [Abstract][Full Text] [Related]
20. Allergic and non-allergic periorbital dermatitis: patch test results of the Information Network of the Departments of Dermatology during a 5-year period.
Herbst RA; Uter W; Pirker C; Geier J; Frosch PJ
Contact Dermatitis; 2004 Jul; 51(1):13-9. PubMed ID: 15291826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
